Aveo Pharmaceutical

Palghar, India Founded: 2015 • Age: 11 yrs Acquired By LG Chem
Drug manufacturing and marketing services are provided by Aveo Pharmaceutical.

About Aveo Pharmaceutical

Aveo Pharmaceutical is a Healthcare company based in Palghar (India) founded in 2015, and was acquired by LG Chem in October 2022. Drug manufacturing and marketing services are provided by Aveo Pharmaceutical. The company has 48 employees. Its Indian entity Meyonex Pharmaceuticals Limited reported revenue of β‚Ή108 Cr. Aveo Pharmaceutical offers products and services including Antidiabetic Tablets, Health Supplements, Cephalosporins, and Oral Suspensions. Its focus areas include Biopharma Outsourcing, Diversified and Biologics.

Company details

Aveo Pharmaceutical was founded in 2015 and is based in Palghar, India. Activities are centered in the pharmaceutical sector, with drug manufacturing and marketing handled as core operations. Other related services are extended to support industry needs. The company is led by Managing Director Arvind Awadhnath Sharma, overseeing functions from its Indian location.

  • Headquarters Palghar, India
  • Employees 48
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website aveo.in
  • Social LinkedIn
  • Acquired by LG Chem (Oct 2022)
  • Legal Name Aveo Pharmaceuticals Pvt. Ltd.
  • Date of Incorporation 17 Jan, 2015
  • Jurisdiction Palghar, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹108 Cr

    FY 2025 · -19% YoY

  • Net Profit
    ₹3.62 Cr

    FY 2025 · 3% margin

  • EBITDA
    ₹10.86 Cr

    FY 2025 · 10% margin

  • Investors
  • Employee Count
    48
  • Acquired by
    LG Chem

    (Oct 2022)

Products & Services of Aveo Pharmaceutical

Aveo Pharmaceutical offers a comprehensive portfolio of products and services, including Antidiabetic Tablets, Health Supplements, Cephalosporins, and Oral Suspensions.

Antidiabetic Tablets
Pharmaceuticals

Tablets for managing diabetes and related health conditions.

Health Supplements
Nutraceuticals

Supplements with vitamins and herbs for general wellness support.

Cephalosporins
Antibiotics

Oral antibiotics for treating bacterial infections effectively.

Oral Suspensions
Formulations

Liquid medications for easy administration to patients.

Investors in Aveo Pharmaceutical

Aveo Pharmaceutical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include LG Chem.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Manufacturer and supplier of automotive battery to OEMs
1947lgchem.comSeoul, South Korea
Premium access

Investor details for Aveo Pharmaceutical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Meyonex Pharmaceuticals Limited (Aveo Pharmaceutical)

Meyonex Pharmaceuticals Limited is the primary company behind Aveo Pharmaceutical. The board of Meyonex Pharmaceuticals Limited currently have 3 directors; the longest-serving is Arvind Awadhnath Sharma, appointed in 2015. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Arvind Awadhnath Sharma
DIN 07011763
Director17 Jan 201511 yrs 9 moMeyonex Pharmaceuticals Limited
Vinod Kumar Sharma
DIN 08083002
Director28 Mar 20188 yrs 7 moMeyonex Pharmaceuticals Limited
Shivani Sharma
DIN 10799469
Additional Director04 Oct 20242 yrsMeyonex Pharmaceuticals Limited

People of Aveo Pharmaceutical

1 people are tracked at Aveo Pharmaceutical (1 in leadership); the tracked headcount is 48.

NameRoleGroup
Managing DirectorLeadership
Premium access

Complete people profiles for Aveo Pharmaceutical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Aveo Pharmaceutical

Figures of Meyonex Pharmaceuticals Limited, the primary company behind Aveo Pharmaceutical, for FY 2025. Revenue was ₹108 Cr (-19% year on year). Net profit was ₹3.62 Cr (3% margin). EBITDA was ₹10.86 Cr (10% margin). Revenue has grown at a compounded annual rate of +26% over three years and +37% over five years.

  • ₹108 CrRevenue · FY 2025 · -19% YoY
  • ₹3.62 CrNet profit · 3% margin
  • ₹10.86 CrEBITDA · 10% margin
  • ₹14.00 CrPaid-up capital
  • 48Employees (provident fund records)
  • +26%Revenue CAGR, 3 years
  • +37%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Meyonex Pharmaceuticals Limited are on its company page.

Premium access

Detailed financial statements for Aveo Pharmaceutical

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Aveo Pharmaceutical

2 dated milestones of Aveo Pharmaceutical across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Aveo Pharmaceutical is founded.
  2. Exit Acquired by LG Chem.

Web traffic of Aveo Pharmaceutical

The website of Aveo Pharmaceutical (aveo.in) receives about 1.7K visits a month.

  • Monthly visits
    1.7K

    ▼ 11% vs previous month

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Aveo Pharmaceutical (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Aveo Pharmaceutical

Premium access

Complete news archive for Aveo Pharmaceutical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aveo Pharmaceutical

Aveo Pharmaceutical was founded in 2015.

Aveo Pharmaceutical is headquartered in Palghar, India. It is registered at Palghar, Maharashtra, India.

Aveo Pharmaceutical has 48 employees.

The primary company behind Aveo Pharmaceutical, Meyonex Pharmaceuticals Limited, reported revenue of β‚Ή108 Cr for FY 2025, down 19% year on year.

Aveo Pharmaceutical was founded in 2015 and is based in Palghar, India. Activities are centered in the pharmaceutical sector, with drug manufacturing and marketing handled as core operations. Other related services are extended to support industry needs. The company is led by Managing Director Arvind Awadhnath Sharma, overseeing functions from its Indian location.

Aveo Pharmaceutical offers Antidiabetic Tablets, Health Supplements, Cephalosporins, and Oral Suspensions.

Aveo Pharmaceutical has 1 investor. Key investors include LG Chem.

Aveo Pharmaceutical operates through Meyonex Pharmaceuticals Limited.

Yes. Aveo Pharmaceutical was acquired by LG Chem in October 2022.

The legal entities of Aveo Pharmaceutical currently have 3 directors, including Arvind Awadhnath Sharma, Vinod Kumar Sharma, Shivani Sharma.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available